JAFFER A AJANI to Bevacizumab
This is a "connection" page, showing publications JAFFER A AJANI has written about Bevacizumab.
Connection Strength
0.188
-
Targeting Angiogenesis in Colorectal Carcinoma. Drugs. 2019 Jan; 79(1):63-74.
Score: 0.128
-
Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. J Clin Oncol. 2008 Mar 10; 26(8):1316-23.
Score: 0.060